Molecular biology of nickel carcinogenesis

M Costa1, J E Sutherland, W Peng

  • 1Department of Environmental Medicine, New York University School of Medicine, NY 10016, USA.

Insights

This review details nickel carcinogenesis mechanisms, focusing on cellular uptake, dissolution, and effects on DNA. Nickel induces gene silencing via DNA hypermethylation and inhibited histone acetylation.

Area of Science:

  • Environmental Health Sciences
  • Molecular Biology
  • Toxicology

Background:

  • Nickel compounds are known human carcinogens.
  • Understanding nickel carcinogenesis is crucial for public health and occupational safety.
  • Decades of research have elucidated various molecular pathways involved.

Purpose of the Study:

  • To review the molecular mechanisms underlying nickel-induced carcinogenesis.
  • To consolidate findings on nickel's interaction with cellular components and genetic material.
  • To provide a comprehensive overview based on extensive laboratory research.

Main Methods:

  • Review of existing research on nickel uptake (soluble and insoluble forms).
  • Analysis of nickel's dissolution within cells.
  • Examination of nickel's effects on cellular heterochromatin.
  • Discussion of nickel's role in gene silencing through epigenetic modifications.

Main Results:

  • Nickel uptake and dissolution are key initial steps in carcinogenesis.
  • Nickel interacts with and alters cellular heterochromatin structure.
  • Nickel induces gene silencing in mammalian cells via DNA hypermethylation.
  • Nickel inhibits histone acetylation in yeast cells, contributing to genetic instability.

Conclusions:

  • Nickel carcinogenesis involves complex molecular events, including epigenetic alterations.
  • Nickel's ability to induce DNA hypermethylation and affect histone acetylation are critical mechanisms.
  • Further research into nickel's genotoxic and epigenetic effects is warranted.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...